![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, March 24, 2014 8:53:05 PM
This is older but still relevant:
http://www.prnewswire.com/news-releases/leading-experts-endorse-biohearts-muscle-stem-cell-myocell-therapy-62128022.html
I am sure Bioheart knows what they are getting into with the FDA. The FDA allowed the reduction of patients for the phase 3 and second part of the Marvel due to the safety shown through the bio statistical data of the previous trials. Myocell has a good chance of approval compared to other potentially toxic drugs out there. If the results show similar safety and efficacy, they are good to go.
Also, I have worked with many regulators who interface with the FDA. Some got certified and came out of totally different professions like an English teacher. He was quite successful at getting our medical devices through. The FDA is tough, but if you follow their rules and answer all of their questions properly, you will be granted approval as long as your labeling and marketing of the drug, biologic or device abides by what it was approved for. They are extremely strict about this believe me.
Again, I strongly encourage you to email or call with any concerns and I am sure you will get some answers.
I'm not concerned at all at this point.
FEATURED Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • Sep 10, 2024 11:00 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM
North Bay Resources Commences Gold Shipments, Fran Gold Project, British Columbia; Enters Taber Gold Mine JV, Sierra County, California • NBRI • Sep 9, 2024 9:15 AM
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM